Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition, we have a very comprehensive practice in the regulation of packaging materials for food, drugs, and cosmetics and other food-contact articles. We represent clients in addressing all issues relating to these products, including the suitability of their composition, inspection of manufacturing facilities, labeling and advertising, recall procedures, quality assurance programs, and appropriate responses to consumer complaints and tampering incidents. We also vigorously defend our clients when threatened by unwarranted action by competitors or regulatory authorities. We also have substantial experience conducting "due diligence" audits of marketed products, labeling, advertising claims, and manufacturing operations, both for the clients' internal control purposes and as part of product line or corporate acquisitions.
More Legal and Business Bylines From Food and Drug Law at Keller and Heckman
- USDA Bioengineered Food Labeling Final Rule Sent to OMB for Review - (Posted On Thursday, September 06, 2018)
- FDA Expands ANAB Recognition under the Accredited Third-Party Certification Program - (Posted On Wednesday, September 05, 2018)
- FDA Announces New Export Certification Program - (Posted On Tuesday, September 04, 2018)
- FDA Issues Statement Regarding Labeling Coffee as a Carcinogen Consistent with California Proposition 65 - (Posted On Friday, August 31, 2018)
- New Proposition 65 Warning Regulations Take Effect Today - (Posted On Thursday, August 30, 2018)
- California Passed Nation’s First Kids’ Meal Bill - (Posted On Wednesday, August 29, 2018)
- GFI and Others Sue Missouri Over Plant-Based and Clean Meat Labeling Law - (Posted On Tuesday, August 28, 2018)
- FDA Recognizes a Fourth Accreditation Body Under FSMA’s VQIP - (Posted On Monday, August 27, 2018)
- Barking News: China Implements New Pet Feed Regulations - (Posted On Friday, August 24, 2018)
- FDA Extends Deadline for Comments on Nutrition Innovation Strategy - (Posted On Friday, August 24, 2018)
Keller and Heckman’s Food and Drug Law Practice Group is a Go-To Thought Leader for 2021 for its coverage of Food Labeling Class Action Lawsuits and Regulatory news. The group regularly provides interesting, comprehensive news on topics ranging from class-action lawsuits involving Snack Foods lacking real Wasabi and Canned Green Beans inaccurately claiming to be preservative-free, to proposed federal legislation regulating CBD in food products. NLR readers appreciate the group’s efforts to break down lawsuits and pending legislation impacting the nation's food supply.
The National Law Review Recognizes Keller and Heckman’s Food and Drug Law Practice Group as Go-To Thought Leaders for the firm’s contributions on FDA Regulations and guidelines. Keller and Heckman’s expansive FDA coverage included: proposed rules expanding food traceability and record-keeping requirements, new guidance for animal food additives, a final rule concerning gluten-free food labeling, and approval of a new peanut allergy drug. Addressing the COVID-19 crisis, Keller & Heckman provided news about warnings required by the FDA for Purell and other actions about hand sanitizer and additional Coronavirus prevention and cure claims, the FDA’s and OSHA’s employee health and food safety checklist(s) and COVID-19 best practices for retail and restaurants and COVID-19 Guidance to U.S. food exporters. The firm’s most frequent FDA / Food and Drug Law attorney contributors to the NLR include Azim Chowdhury, Sheila A. Millar, Evangelia Pelonis, Natalie Rainer and LieAnn Van-Tull.